[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Neuromyelitis Optica Drug Market Research Report 2012-2024

July 2019 | 81 pages | ID: G8056E544E9EN
HeyReport

US$ 2,290.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.

The global Neuromyelitis Optica Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Production Market Share
  • Price Rage
  • Cost
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Pfizer
  • FRESENIUS
  • TEVA
  • SANDOZ
  • Intas
  • Gyjtrs
  • NANG KUANG
  • Tianjin Kingyork
  • Baxter
  • CSL
  • Grifols
  • Octapharma
  • CBOP
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Acute attack
  • Remission prophylactic treatment
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 Production Market Share
    1.2.1.2 Price Rage
    1.2.1.3 Cost
  1.2.2 by Application
    1.2.2.1 Acute attack
    1.2.2.2 Remission prophylactic treatment
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Production Market Share Market, 2013-2018
  4.1.2 Price Rage Market, 2013-2018
  4.1.3 Cost Market, 2013-2018
4.2 Market Forecast
  4.2.1 Production Market Share Market Forecast, 2019-2024
  4.2.2 Price Rage Market Forecast, 2019-2024
  4.2.3 Cost Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Acute attack Market, 2013-2018
  5.1.2 Remission prophylactic treatment Market, 2013-2018
5.2 Market Forecast
  5.2.1 Acute attack Market Forecast, 2019-2024
  5.2.2 Remission prophylactic treatment Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Pfizer
8.2 FRESENIUS
8.3 TEVA
8.4 SANDOZ
8.5 Intas
8.6 Gyjtrs
8.7 NANG KUANG
8.8 Tianjin Kingyork
8.9 Baxter
8.10 CSL
8.11 Grifols
8.12 Octapharma
8.13 CBOP

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Neuromyelitis Optica Drug
Table Products Segment of Neuromyelitis Optica Drug
Table Production Market Share Overview
Table Price Rage Overview
Table Cost Overview
Table Global Neuromyelitis Optica Drug Market by Type, 2011-2022 (USD Million)
Table Application Segment of Neuromyelitis Optica Drug
Table Acute attack Overview
Table Remission prophylactic treatment Overview
Table Global Neuromyelitis Optica Drug Market by Application, 2011-2022 (USD Million)
Table Global Neuromyelitis Optica Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Neuromyelitis Optica Drug
Table Market Dynamics
Table Policy of Neuromyelitis Optica Drug
Table GDP of Major Countries
Table Production Market Share CAGR by Revenue and Volume, 2012-2018
Table Price Rage CAGR by Revenue and Volume, 2012-2018
Table Cost CAGR by Revenue and Volume, 2012-2018
Table Production Market Share CAGR by Revenue and Volume, 2012-2024
Table Price Rage CAGR by Revenue and Volume, 2012-2024
Table Cost CAGR by Revenue and Volume, 2012-2024
Table Acute attack CAGR by Revenue and Volume, 2012-2018
Table Remission prophylactic treatment CAGR by Revenue and Volume, 2012-2018
Table Global Neuromyelitis Optica Drug Market by Vendors, 2012-2018 (USD Million)
Table Global Neuromyelitis Optica Drug Market by Vendors, 2012-2018 (in Volume)
Table Global Neuromyelitis Optica Drug Market Share by Vendors, 2012-2018 (USD Million)
Table Global Neuromyelitis Optica Drug Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FRESENIUS Profile List
Table Microecological Modulator Operating Data of FRESENIUS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TEVA Profile List
Table Microecological Modulator Operating Data of TEVA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SANDOZ Profile List
Table Microecological Modulator Operating Data of SANDOZ (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Profile List
Table Microecological Modulator Operating Data of Intas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gyjtrs Profile List
Table Microecological Modulator Operating Data of Gyjtrs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NANG KUANG Profile List
Table Microecological Modulator Operating Data of NANG KUANG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tianjin Kingyork Profile List
Table Microecological Modulator Operating Data of Tianjin Kingyork (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Baxter Profile List
Table Microecological Modulator Operating Data of Baxter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Profile List
Table Microecological Modulator Operating Data of CSL (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Grifols Profile List
Table Microecological Modulator Operating Data of Grifols (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Octapharma Profile List
Table Microecological Modulator Operating Data of Octapharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CBOP Profile List
Table Microecological Modulator Operating Data of CBOP (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Neuromyelitis Optica Drug Picture
Figure Industry Chain Structure of Neuromyelitis Optica Drug
Figure SWOT of Neuromyelitis Optica Drug
Figure Production Market Share Market Size and Growth, 2012-2018 (USD Million)
Figure Production Market Share Market Size and Growth, 2012-2018 (in Volume)
Figure Price Rage Market Size and Growth, 2012-2018 (USD Million)
Figure Price Rage Market Size and Growth, 2012-2018 (in Volume)
Figure Cost Market Size and Growth, 2012-2018 (USD Million)
Figure Cost Market Size and Growth, 2012-2018 (in Volume)
Figure Production Market Share Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Production Market Share Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Price Rage Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Price Rage Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Cost Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Cost Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Acute attack Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Remission prophylactic treatment Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Neuromyelitis Optica Drug Market Concentration by Region
Figure Marketing Channels Overview


More Publications